The Effect of Using Virtual Reality Glasses on Post-Care Pain and Comfort Level in Intensive Care Patients

April 5, 2025 updated by: Emre Şahin, Çankırı Karatekin University
The aim of this study is to determine the level of pain and comfort associated with the implementation of virtual reality prior to nursing care in patients undergoing treatment in the intensive care unit. The research will be conducted in the Internal Medicine Intensive Care Unit of a university hospital.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The aim of this study is to determine the level of pain and comfort associated with the implementation of virtual reality prior to nursing care in patients undergoing treatment in the intensive care unit.

The study will be conducted in the Internal Medicine Intensive Care Unit of a university hospital. The study population will consist of patients admitted to the internal medicine unit who are between 18 and 65 years of age, are conscious with a Glasgow Coma Scale (GCS) score of 10 or above, have no auditory or visual impairments, and are not receiving mechanical ventilation support.

A total of 60 patients will be included in the study and randomly assigned into two groups: 30 in the experimental group and 30 in the control group.

Data will be collected through face-to-face interviews using a Sociodemographic Characteristics and Information Description Form, a Visual Analog Scale (VAS), and the General Comfort Scale - Short Form (GCS-SF).

The intervention for the experimental group will include viewing calming videos using a virtual reality headset before nursing care. Pain and general comfort levels will be evaluated 24 hours after the nursing care procedure.

Statistical analyses such as percentage calculations, t-test, Mann-Whitney U test, and Spearman correlation analysis will be used to evaluate the data.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Çankırı, Turkey
        • Çankırı Karatekin Üniversitesi

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Individuals who are hospitalized in the intensive care unit (with diagnoses such as cancer, chronic renal failure, heart failure, gastrointestinal bleeding, COPD, DM, etc.) and volunteer to participate in the study.
  • Between the ages of 18-65,
  • Having clear consciousness, orientation to place, time and person, and having a GCS score of 10 and above,
  • Individuals who do not have any hearing or visual impairment,
  • They were determined as individuals who were not on mechanical ventilation support.

Exclusion Criteria:

  • Receiving mechanical ventilation support
  • Individuals under 18 years of age and over 65 years of age

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: virtual reality
During care, patients are given a duration of 3-10 minutes. virtual reality glasses (VR box 2.0 virtual glasses) for a total of 15 minutes walks in parks, nature and seaside with music background, with reality glasses (6.5 inches), videos that the patient wants to watch and whenever he/she wants, such as underwater or museum tours. Videos that could be changed were shown.
Other: virtual reality, experimental group
Socio-demographic characteristics form questions were asked to individuals in the intervention group before care. During the care, patients are given virtual reality glasses (VR box 2.0 virtual reality glasses and 6.5 inch) for a total of 15 minutes, ranging from 3 to 10 minutes, and watch videos that the patient wants to watch, such as park, nature and seaside walks, undersea and museum trips, with a music background. and he was shown videos that he could change at any time. After the maintenance, Visual Analog Scale-Pain (VAS-P) scale, General Comfort Level Scale and Satisfaction Evaluation Scale for Virtual Reality Glasses Application questions were applied. 24 hours after the care, VAS-P and General Comfort Level Scale were administered again.
Other: control group
A socio-demographic questionnaire was administered to the control group before care. During maintenance, no intervention was applied and standard care in routine practice was applied. After the care, Visual Analog Scale-Pain (VAS-P) scale and General Comfort Scale were applied. 24 hours after the treatment, the Visual Analog Scale-Pain (VAS-P) scale and the General Comfort Scale were applied again.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Pain Level Measured by Visual Analog Scale (VAS) Before and After Nursing Care
Time Frame: 24 hours
Pain will be assessed using the Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate worse pain. Pain levels will be measured before care and again 24 hours after nursing care, and compared between the experimental and control groups.
24 hours
Change in Overcoming Problems Sub-dimension and General Comfort Level (GCS-SF) After Virtual Reality Application
Time Frame: 24 hours
Comfort will be assessed using the General Comfort Scale - Short Form (GCS-SF), including the "overcoming problems" sub-dimension. The GCS-SF total score ranges from 24 to 96, with higher scores indicating greater comfort. Scores will be measured 24 hours after the virtual reality application in both the experimental and control groups.
24 hours
Change in Refreshment/Comfort Sub-Dimension Scale Score After Virtual Reality Application
Time Frame: 24 hours
Comfort will be evaluated using the Refreshment/Comfort sub-dimension of the General Comfort Scale - Short Form (GCS-SF). Scores range from 8 to 32, with higher scores indicating greater comfort. Scores will be measured 24 hours after the virtual reality application in both the experimental and control groups.
24 hours

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Satisfaction Survey Score Related to the Use of Virtual Reality Glasses in the Experimental Group
Time Frame: 24 hours
Participants in the experimental group will wear virtual reality glasses during nursing care. Their satisfaction will be evaluated through a self-report questionnaire using a scale ranging from 0 (not satisfied at all) to 10 (extremely satisfied). Higher scores indicate greater satisfaction. The survey will be administered 24 hours after the intervention.
24 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Çankırı Karatekin University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2022

Primary Completion (Actual)

December 31, 2022

Study Completion (Actual)

January 15, 2024

Study Registration Dates

First Submitted

March 21, 2024

First Submitted That Met QC Criteria

April 5, 2025

First Posted (Actual)

April 11, 2025

Study Record Updates

Last Update Posted (Actual)

April 11, 2025

Last Update Submitted That Met QC Criteria

April 5, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CankırıKU-HEM-ES-01

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Heart Failure

Clinical Trials on virtual reality, experimental group

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Rwanda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe